Fundraising FoxRodeo Therapeutics
Seattle, US · Founded 2017 · Delaware corporation · 3 known investors
Find your way into Rodeo Therapeutics
Sign up to see every warm intro you have to Rodeo Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Rodeo Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
Rodeo Therapeutics was founded in 2017 by Sanford Markowitz.
SM
Sanford MarkowitzFounder
TL
Thong LeNamed on SEC filing
DS
David SchubertNamed on SEC filing
JS
James SullivanNamed on SEC filing
LR
Lindsay RayleNamed on SEC filing
TY
Tadataka YamadaNamed on SEC filing
Board
AX
Asish XavierBoard director
SG
JM
Investors · 3
CWRU Technology Ventureslisted by CWRU Technology VenturesCleveland · $50K – $250K
How we know: CWRU Technology Ventures's portfolio page · Not right? Tell us
AlexandriareportedPasadena
How we know: funding news · Not right? Tell us
ARCH Venture PartnersreportedChicago · $50K – $250M
How we know: funding news · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$14.3M disclosed across 2 rounds · 2017–2018
▶$8.9MraisedApr 2020 · 9 investors · BiotechnologyRule 506(b)
▶$8.9MraisedApr 2020 · 9 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Kendall MohlerExecutive Officer
- Margarita ChavezDirector
- Katie HewittDirector
- Thong LeExecutive Officer, Director, Promoter
- Tadataka YamadaDirector
- Asish XavierDirector
- Suzanne RettenmierExecutive Officer
- Sanford MarkowitzDirector
- Ian HowesExecutive Officer
- Steve GillisDirector
- Offering amount
- $8.9M
- Amount sold
- $8.9M
- First sale
- Nov 2018
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
▶$5.4MraisedAug 2017 · 8 investors · BiotechnologyRule 506(b)
▶$5.4MraisedAug 2017 · 8 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Asish XavierDirector
- Steve GillisDirector
- Thong LeExecutive Officer, Director, Promoter
- David SchubertExecutive Officer, Promoter
- Sanford MarkowitzDirector
- James SullivanDirector
- Lindsay RayleExecutive Officer, Promoter
- Joel MarcusDirector
- Tadataka YamadaDirector
- Offering amount
- $5.9M
- Amount sold
- $5.4M
- First sale
- Jul 2017
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who founded Rodeo Therapeutics?
- Rodeo Therapeutics was founded by Sanford Markowitz in 2017.
- Who are Rodeo Therapeutics's investors?
- Rodeo Therapeutics's investors include CWRU Technology Ventures, Alexandria, ARCH Venture Partners.
- How much funding has Rodeo Therapeutics raised?
- Rodeo Therapeutics has disclosed $14.3M raised across 2 rounds.
- Where is Rodeo Therapeutics headquartered?
- Rodeo Therapeutics is headquartered in Seattle, US.